Laurus Labs

77
Buy
  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE947Q01028
  • NSEID: LAURUSLABS
  • BSEID: 540222
INR
1,025.15
12.5 (1.23%)
BSENSE

Dec 05

BSE+NSE Vol: 5.32 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Operating Income
5,040.00
6,040.00
4,935.00
4,813.00
2,831.00
2,291.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
5,040.00
6,040.00
4,935.00
4,813.00
2,831.00
2,291.00
Expenditure (Ex Depriciation)
Stock Adjustments
-100.00
22.00
-221.00
-297.00
-216.00
-31.00
Raw Materials Consumed
2,533.00
2,752.00
2,414.00
2,455.00
1,629.00
1,267.00
Power & Fuel Cost
338.00
324.00
204.00
157.00
136.00
109.00
Employee Cost
639.00
580.00
501.00
434.00
344.00
289.00
Operating Expenses
506.00
451.00
350.00
296.00
193.00
153.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
134.00
116.00
101.00
91.00
61.00
31.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
31.00
46.00
15.00
10.00
11.00
17.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
4,263.00
4,448.00
3,513.00
3,262.00
2,267.00
1,935.00
Operating Profit (PBDIT) excl Other Income
777.00
1,592.00
1,422.00
1,550.00
564.00
355.00
Other Income
26.00
6.00
15.00
23.00
5.00
16.00
Operating Profit (PBDIT)
803.00
1,598.00
1,437.00
1,574.00
570.00
372.00
Interest
182.00
165.00
102.00
68.00
89.00
88.00
Profit before Depriciation and Tax
620.00
1,433.00
1,335.00
1,506.00
480.00
283.00
Depreciation
384.00
324.00
251.00
205.00
187.00
164.00
Profit Before Taxation & Exceptional Items
236.00
1,108.00
1,083.00
1,301.00
293.00
119.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
236.00
1,108.00
1,083.00
1,301.00
293.00
119.00
Provision for Tax
68.00
312.00
251.00
317.00
38.00
25.00
Profit After Tax
168.00
796.00
832.00
983.00
255.00
93.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
3,302.00
2,624.00
1,883.00
987.00
771.00
696.00
Profit Available for appropriations
3,462.00
3,415.00
2,710.00
1,971.00
1,026.00
790.00
Appropriations
3,462.00
3,415.00
2,710.00
1,971.00
1,026.00
790.00
Equity Dividend (%)
40.00%
100.00%
100.00%
100.00%
25.00%
15.00%
Earnings Per Share
2.98
14.69
15.42
18.36
4.79
8.83
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 8.41% vs -16.65% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 25.93% vs -49.39% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 20.81% vs 3.51% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 70.04% vs -70.58% in Mar 2024

Compare Profit and Loss Results of Laurus Labs
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
5,040.00
13,321.00
-8,281.00
-62.17%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
5,040.00
13,321.00
-8,281.00
-62.17%
Expenditure (Ex Depriciation)
Stock Adjustments
-100.00
-213.00
113.00
53.05%
Raw Materials Consumed
2,533.00
4,567.00
-2,034.00
-44.54%
Power & Fuel Cost
338.00
131.00
207.00
158.02%
Employee Cost
639.00
3,022.00
-2,383.00
-78.86%
Operating Expenses
506.00
701.00
-195.00
-27.82%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
134.00
1,270.00
-1,136.00
-89.45%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
31.00
787.00
-756.00
-96.06%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
4,263.00
10,970.00
-6,707.00
-61.14%
Operating Profit (PBDIT) excl Other Income
777.00
2,351.00
-1,574.00
-66.95%
Other Income
26.00
113.00
-87.00
-76.99%
Operating Profit (PBDIT)
803.00
2,465.00
-1,662.00
-67.42%
Interest
182.00
207.00
-25.00
-12.08%
Profit before Depriciation and Tax
620.00
2,258.00
-1,638.00
-72.54%
Depreciation
384.00
486.00
-102.00
-20.99%
Profit Before Taxation & Exceptional Items
236.00
1,772.00
-1,536.00
-86.68%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
236.00
1,399.00
-1,163.00
-83.13%
Provision for Tax
68.00
352.00
-284.00
-80.68%
Profit After Tax
168.00
1,047.00
-879.00
-83.95%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
3,302.00
7,870.00
-4,568.00
-58.04%
Profit Available for appropriations
3,462.00
8,917.00
-5,455.00
-61.18%
Appropriations
3,462.00
8,917.00
-5,455.00
-61.18%
Equity Dividend (%)
40%
250%
-210.00
Earnings Per Share
2.98
37.11
-34.13
-91.97%
Profit And Loss - Net Sales
Net Sales 5,216.98 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 8.41% vs -16.65% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 944.33 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 25.93% vs -49.39% in Mar 2024

Profit And Loss - Interest
Interest 182.20 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 20.81% vs 3.51% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 380.39 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 70.04% vs -70.58% in Mar 2024